Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on May 16, 2012. The report discloses insider trading activities under Item 7.01 (Regulation FD Disclosure) involving the company's Chairman, CEO, Executive Vice Chairman, General Counsel, and CFO.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and insider trading plan updates rather than financial performance.
Material Changes
- Executive Trading Plans: Russell C. Horowitz (Chairman/CEO), John Keister (Executive Vice Chairman), and Ethan Caldwell (General Counsel/CAO) terminated their previously established Rule 10b5-1 sales plans.
- New Purchase Plans: The aforementioned executives entered into new Rule 10b5-1 purchase plans to buy shares of Marchex Class B common stock in open market transactions for the remainder of the year.
- CFO Activity: Michael Arends (CFO) commenced purchasing shares of Marchex Class B common stock on May 16, 2012.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or specific risk factors. Management commentary is limited to the confirmation that the new purchase plans were adopted in accordance with the company's Code of Conduct and are intended to qualify for the safe harbor under Rule 10b5-1. The information is furnished and not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific share amounts and price limitations within the new Rule 10b5-1 purchase plans via future Form 4 filings.
- Confirm the cessation of the previous sales plans for Messrs. Horowitz, Keister, and Caldwell.
- Monitor subsequent filings for the execution of purchases by the CFO and other executives.